Aldactone and Cholecystitis infective - a phase IV clinical study of FDA data

Summary:

Cholecystitis infective is reported as a side effect among people who take Aldactone (spironolactone), especially for people who are male, 60+ old, also take Plavix, and have Gout.

The phase IV clinical study analyzes which people have Cholecystitis infective when taking Aldactone. It is created by eHealthMe based on reports of 45,404 people who have side effects when taking Aldactone from the FDA, and is updated regularly.

What is Aldactone?

Aldactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 46,063 Aldactone users. Check the latest studies of Aldactone.

What is Cholecystitis infective?

Cholecystitis infective (infection of gallbladder capable to infect other organs) is found to be associated with 390 drugs and 405 conditions by eHealthMe. Check the latest studies of Cholecystitis infective.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

45,404 people reported to have side effects when taking Aldactone.
Among them, 12 people (0.03%) have Cholecystitis infective.

Could Aldactone cause Cholecystitis infective?

Among these 12 people:

What is the gender of people who have Cholecystitis infective when taking Aldactone? *

female: 8.33 %
male: 91.67 %

What is the age of people who have Cholecystitis infective when taking Aldactone? *

What are other drugs people take besides Aldactone? *

What are other side effects people have besides Cholecystitis infective? *

Weakness: 3 people, 25.00%
Myopathy (a muscular disease in which the muscle fibres do not function): 3 people, 25.00%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 25.00%
Benign Neoplasm Of Skin (benign (non-cancerous) tumours of the skin): 3 people, 25.00%
Blood Lactate Dehydrogenase Increased: 3 people, 25.00%
Cardiac Pacemaker Replacement: 3 people, 25.00%
Colitis (inflammation of colon): 3 people, 25.00%
Csf Volume Increased: 3 people, 25.00%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 25.00%
Gait Disturbance: 3 people, 25.00%

What are the existing conditions these people have? *

Parathyroid Disorder: 3 people, 25.00%
Pain: 3 people, 25.00%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 25.00%
Gout (uric acid crystals building up in the body): 3 people, 25.00%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 2 people, 16.67%
Micturition Urgency (urgency to pass the urine): 2 people, 16.67%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 16.67%
Gastrointestinal Motility Disorder (abnormal intestinal contractions): 2 people, 16.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 16.67%
Gastric Ulcer (stomach ulcer): 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Aldactone and have Cholecystitis infective?

- Check whether Cholecystitis infective is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aldactone:

Aldactone (46,063 reports)

Browse all side effects of Aldactone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cholecystitis infective:

Cholecystitis infective (390 drugs)

Browse all the conditions that are associated with Cholecystitis infective:

Cholecystitis infective (405 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on spironolactone (the active ingredients of Aldactone) and Aldactone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.